Sarclisa Uniunea Europeană - română - EMA (European Medicines Agency)

sarclisa

sanofi winthrop industrie - isatuximab - mielom multiplu - agenți antineoplazici - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

TRITACE PLUS 5 mg/25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tritace plus 5 mg/25 mg

sanofi s.r.l. - italia - combinatii (ramiprilum+hydrochlorothiazidum) - compr. - 5mg/25mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si diuretice - combinati

HEXORALETTEN N 5 mg+1,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

hexoraletten n 5 mg+1,5 mg

mcneil products limited c/o johnson&johnson ltd. - combinatii (chlorhexidinum+benzocainum) - pastile - 5mg+1,5mg - medicamente pentru zona oro-faringiana antiseptice

TACROLIMUS SANDOZ 5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

tacrolimus sandoz 5 mg

lek pharmaceuticals d.d. - germania - tacrolimusum - caps. - 5mg - imunosupresoare inhibitori de calcineurina

Fer Rompharm solutie injectabila 100 mg/2 ml Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

fer rompharm solutie injectabila 100 mg/2 ml

rompharm company srl, sc - de fier (iii) hydroxidum cu polymaltosi complexe - solutie injectabila - 100 mg/2 ml